OXALTIN 50 MG

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

OXALIPLATIN 50 MG

MAH:

PERRIGO ISRAEL AGENCIES LTD

ATC_code:

L01XA03

pharmaceutical_form:

POWDER FOR SOLUTION FOR INFUSION

administration_route:

I.V

manufactured_by:

ACTAVIS ITALY S.P.A

therapeutic_group:

OXALIPLATIN

therapeutic_indication:

Oxaliplatin in combination with 5-fluorouracil (5-FU) and folinic acid (FA) is indicated for:- Adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of primary tumour.-Treatment of metastatic colorectal cancer.

authorization_date:

2013-08-01